NASA astronaut Anil Menon and two Russian cosmonauts successfully docked with the International Space Station on Tuesday, July 14, 2026, marking the start of an eight-month research mission. The crew launched from the Baikonur Cosmodrome in Kazakhstan aboard a Russian Soyuz MS-29 spacecraft. Their arrival brings the total number of people aboard the orbiting laboratory to ten, as they join the existing Expedition 74 crew for a brief handover period before the start of Expedition 75.
Menon, a U.S. Space Force colonel and emergency medicine physician, was selected as a NASA astronaut in 2021. His mission is heavily focused on human health and the physiological challenges of long-duration spaceflight. Throughout his stay, he will conduct experiments to study how microgravity affects blood flow and vein structure. These findings are intended to help researchers develop better medical protocols to protect future astronauts traveling to the Moon and Mars.
Beyond human physiology, the mission includes significant technology demonstrations. Menon will test a system designed to produce intravenous fluids from the station's existing water supply, a critical capability for deep-space travel where resupply missions are not possible. He will also participate in research on manufacturing semiconductor crystals in microgravity, which could lead to more efficient components for high-performance computers and medical devices on Earth.
This mission represents a major milestone for the 49-year-old astronaut, who previously served as SpaceX's first flight surgeon and supported various NASA expeditions. As the station continues its role as a unique laboratory, the work performed by Menon and his crewmates remains essential for advancing both space exploration and scientific innovation that benefits life on the ground.